To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma
Clinical trial NCT04582539 · TERMINATED
Trial details
- NCT number
- NCT04582539
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-19
- Primary completion
- 2024-08-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.